APA (7th ed.) Citation

Cristaudo, A., Graceffa, D., Pimpinelli, F., Sperati, F., Spoletini, G., Bonifati, C., . . . Morrone, A. (2022). Immunogenicity and safety of anti‐SARS‐CoV‐2 BNT162b2 vaccine in psoriasis patients treated with biologic drugs. Journal of the European Academy of Dermatology & Venereology, 36(4), e266. https://doi.org/10.1111/jdv.17861

Chicago Style (17th ed.) Citation

Cristaudo, A., et al. "Immunogenicity and Safety of Anti‐SARS‐CoV‐2 BNT162b2 Vaccine in Psoriasis Patients Treated with Biologic Drugs." Journal of the European Academy of Dermatology & Venereology 36, no. 4 (2022): e266. https://doi.org/10.1111/jdv.17861.

MLA (9th ed.) Citation

Cristaudo, A., et al. "Immunogenicity and Safety of Anti‐SARS‐CoV‐2 BNT162b2 Vaccine in Psoriasis Patients Treated with Biologic Drugs." Journal of the European Academy of Dermatology & Venereology, vol. 36, no. 4, 2022, p. e266, https://doi.org/10.1111/jdv.17861.